Diagnosis and treatment of mantle cell lymphoma.

@article{Hitz2013DiagnosisAT,
  title={Diagnosis and treatment of mantle cell lymphoma.},
  author={Felicitas Hitz and Mario Bargetzi and Sergio B Cogliatti and Andreas Lohri and Christian J Taverna and Christoph Renner and Ulrich Mey},
  journal={Swiss medical weekly},
  year={2013},
  volume={143},
  pages={
          w13868
        }
}
Mantle cell lymphoma (MCL) is a relatively rare lymphoma entity accounting for an estimated 3%-6% of all non-Hodgkin's lymphoma cases. Characterised by both the incurability of indolent lymphomas and the rapid growth of aggressive lymphomas, MCL has a median overall survival of only 4-5 years. Although the disease often shows an encouraging response to first-line treatment, its clinical course is usually marked by recurrent relapses, resulting in a dismal long-term outcome. The choice of… CONTINUE READING
5 Citations
91 References
Similar Papers

References

Publications referenced by this paper.
Showing 1-10 of 91 references

Similar Papers

Loading similar papers…